April 26, 2022 PAO-04-22-R250-72
At another stop on Pharma's Almanac's Road to 50 States trip, Don Turner, Chairman and CEO at Neosinus Health, talks to Nigel about the great potential of intranasal drug delivery and how Neosinus Health has used physiology, anatomy, and physics to optimize the delivery method.
Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.